"Markov Chains" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A stochastic process such that the conditional probability distribution for a state at any future instant, given the present state, is unaffected by any additional knowledge of the past history of the system.
| Descriptor ID |
D008390
|
| MeSH Number(s) |
E05.318.740.600.500 E05.318.740.996.500 G17.830.500 N05.715.360.750.625.500 N05.715.360.750.770.500 N06.850.520.830.600.500 N06.850.520.830.996.500
|
| Concept/Terms |
Markov Chains- Markov Chains
- Chains, Markov
- Markov Process
- Markov Processes
- Process, Markov
- Processes, Markov
- Markov Chain
- Chain, Markov
|
Below are MeSH descriptors whose meaning is more general than "Markov Chains".
Below are MeSH descriptors whose meaning is more specific than "Markov Chains".
This graph shows the total number of publications written about "Markov Chains" by people in this website by year, and whether "Markov Chains" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 1 | 4 | 5 |
| 2006 | 0 | 4 | 4 |
| 2007 | 0 | 6 | 6 |
| 2008 | 1 | 8 | 9 |
| 2009 | 0 | 3 | 3 |
| 2010 | 1 | 9 | 10 |
| 2011 | 0 | 3 | 3 |
| 2012 | 1 | 9 | 10 |
| 2013 | 1 | 11 | 12 |
| 2014 | 1 | 8 | 9 |
| 2015 | 3 | 9 | 12 |
| 2016 | 3 | 5 | 8 |
| 2017 | 2 | 7 | 9 |
| 2018 | 0 | 3 | 3 |
| 2019 | 1 | 4 | 5 |
| 2020 | 0 | 6 | 6 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
| 2024 | 3 | 4 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Markov Chains" by people in Profiles.
-
Economic Value of Bronchoscopy Technologies that Improves Sensitivity for Malignancy for Peripheral Pulmonary Lesions. Ann Am Thorac Soc. 2024 Dec; 21(12):1759-1769.
-
Estimating sojourn time and sensitivity of screening for ovarian cancer using a Bayesian framework. J Natl Cancer Inst. 2024 Nov 01; 116(11):1798-1806.
-
Accurate identification of locally aneuploid cells by incorporating cytogenetic information in single cell data analysis. Sci Rep. 2024 10 15; 14(1):24152.
-
Impact of adherence on the cost-effectiveness of apixaban and rivaroxaban in stroke prevention among patients with atrial fibrillation in the United States. Expert Rev Pharmacoecon Outcomes Res. 2025 Jan; 25(1):63-70.
-
What Is the Economic Benefit of Annual COVID-19 Vaccination From the Adult Individual Perspective? J Infect Dis. 2024 Aug 16; 230(2):382-393.
-
The Cost-Effectiveness of Omalizumab for Treatment of Food Allergy. J Allergy Clin Immunol Pract. 2024 Sep; 12(9):2481-2489.e1.
-
Markov models for clinical decision-making in radiation oncology: A systematic review. J Med Imaging Radiat Oncol. 2024 Aug; 68(5):610-623.
-
Estimation of non-monotonic transition rates in?a?semi-Markov process with covariates adjustments and?application to caregivers' stress data. Stat Med. 2023 12 30; 42(30):5646-5656.
-
Integrative Bayesian models using Post-selective inference: A case study in radiogenomics. Biometrics. 2023 09; 79(3):1801-1813.
-
On Bayesian modeling of censored data in JAGS. BMC Bioinformatics. 2022 Mar 23; 23(1):102.